Blogs

Elliott Wave Update of USDCAD – December 27, 2023

Forex

USDCAD is down again this week as its inverse correlation with the price of crude oil seems to have finally returned. Is there a support in sight? Read in our latest Elliott Wave update. <div> <div> To access this article you need to have an active <a href="https://ewminteractive.com/elliott-wave-pro/">subscription</a

Quant (QNTUSD) Looks Tasty for the Bulls

Forex

<p>Get the 7 Step Checklist Johnathon Fox Uses to Find Every High Probability Price Action Trade</p> <p>Quant Price Forecast: December 27The Quant (QNTUSD) pair is making positive moves and looks tasty for the bulls as the price now trades very close to the upper resistance level. The crypto can swing up further above the current

EURJPY Exhibits Thinning Activity

Forex

<p>Get the 7 Step Checklist Johnathon Fox Uses to Find Every High Probability Price Action Trade</p> <p>The holiday season seems to be exerting a limiting effect on the EURJPY market, restricting price movements. Technical indicators show some divergence, but they might eventually provide support. Key Price Levels: Resistance Leve

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Forex

<p>Tarrytown, NY and New York, NY, Dec. 27, 2023 (GLOBE NEWSWIRE) — Visiox Pharmaceuticals, Inc. (“Visiox” or the “Company”), a commercial-stage biopharmaceutical company, and PowerUp Acquisition Corp. (“PowerUp”) (Nasdaq: PWUP) today announced the execution of a definitive agreement for a business combination (the “Transaction” or the

NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease

Forex

<p>NKGen’s SNK01 program continues to show positive progress with the FDA IND clearance in October 2023, and now the CTA clearance by Health Canada for a phase 1/2a clinical trial in moderate Alzheimer’s Disease patients Based on data generated from its Phase I dose escalation safety trial, presented at the recent CTAD conference in October [

Page 1016 of 9786